Trials / Completed
CompletedNCT01987167
Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis
Potential Neuroprotection With ACTHAR Following Acute Optic Neuritis
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Neuro-Ophthalmologic Associates, PC · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of the study is to determine the earliest structural changes in the optic nerve during the acute event and during the twelve months of recovery following Acthar treatment.
Detailed description
Determine the earliest structural changes in the optic nerve during the acute event and during the twelve months of recovery following Acthar treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACTHAR | Injectable Gel |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2013-11-19
- Last updated
- 2017-08-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01987167. Inclusion in this directory is not an endorsement.